codexis.com (CDXS): Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi

Codexis (CDXS) tovar belgisi

Codexis, Inc. (CDXS) kompaniyasining kunlik narxlar grafigi sog'liqni saqlash gigantlari bilan tuzilgan ko'p yillik shartnomalardan kelib chiqadigan pul oqimining barqarorligini tasdiqlaydi, bunda ko'rsatkich 1.92 darajasida turibdi. Daromadlar oqsillar savdosi va kimyo sanoati uchun katalizatorlarni litsenziyalashga asoslangan. Biznesni rivojlantirish noyob fermentlarni tezkor muhandisligi uchun CodeEvolver tizimidan foydalanadigan global korporatsiyalar bilan ittifoqlarga tayanadi.

codexis.com (CDXS): Uzoq muddatli qarzning kapitalga nisbati 04.07.2022dan 27.10.2026gacha

Codexis Inc (CDXS) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kursi Codexis Bio|CDXS - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Codexis|CDXS - Korxona qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Codexis, Inc.|CDXS - Balans kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati codexis.com|CDXS - Kompaniyaning jami aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning kapitalga nisbati Codexis, Inc.|CDXS - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi Codexis Bio|CDXS - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Codexis
Kompaniyaning jamlanma tahliliyoti:CDXS codexis.com
codexis.com asosiy tovari

Codexis, Inc. (CDXS) uchun uzoq muddatli majburiyatlarning kapitalga nisbatini tahlil qilish biokatalizatorlar ishlab chiqarishni kengaytirish kontekstida kompaniyaning moliyaviy barqarorligini baholash imkonini beradi. Ushbu ko'rsatkich bir yildan ortiq muddatli kreditlarni kapital bilan solishtiradi va farmatsevtika sanoati sherikliklarini kengaytirish davomida haddan tashqari kredit yuklamasi yoki resurslardan samarasiz foydalanish risklarini aniqlaydi, bu esa emitent balansining umumiy tuzilishi mustahkamligini tasdiqlaydi.

Codexis, Inc. raqobatchilari

Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi TEM|Uzoq muddatli qarzning o'z kapitaliga nisbati Qiagen Group QGEN|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Isis Pharmaceuticals (IONS)|Uzoq muddatli qarzning kapitalga nisbati RGEN (Repligen Corporation)|Uzoq muddatli qarzning kapitalga nisbati aviditybiosciences.com RNA|CRSP: Uzoq muddatli qarzning kapitalga nisbati|WGS: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati RARE|Beam Tx (BEAM) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Sarepta Therapeutics, Inc. (SRPT)|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi twistbioscience.com|10x Genomics - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Intellia Therapeutics Inc NTLA|STOK - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BioLife BLFS|Uzoq muddatli qarzning kapitalga nisbati WVE (Wave Life Sciences)|MAZE: Uzoq muddatli qarzdorlikning kapitalga nisbati|Sionna Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Prime Medicine Inc|TSHA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti uniQure Pharma|MGTX (MeiraGTx Holdings plc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati RGNX (regenxbio.com)|SLDB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Ocugen Inc OCGN|PACB: Uzoq muddatli qarzning kapitalga nisbati|Benitec Corp (BNTC) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Design Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|rocketpharma.com (RCKT) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati FDMT|Uzoq muddatli qarzning o'z kapitaliga nisbati Lexeo|Uzoq muddatli qarzning kapitalga nisbati Korro Bio, Inc. KRRO|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Editas Corp EDIT|SLN - Uzoq muddatli qarzning o'z kapitaliga nisbati|ProQR - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning o'z kapitaliga nisbati SGMO (Sangamo Therapeutics, Inc.)|NAUT - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Metagenomi, Inc|DTIL (Precision BioSciences Inc.) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning o'z kapitaliga nisbati Generation Bio Co (GBIO)|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi boundlessbio.com|Uzoq muddatli qarzning kapitalga nisbati XCUR|Uzoq muddatli qarzning kapitalga nisbati imunon.com (IMNN)|Phio Pharmaceuticals Corp. - Uzoq muddatli qarzning kapitalga nisbati|Mustang Bio Inc - Uzoq muddatli qarzning o'z kapitaliga nisbati|RNAZ (TransCode) - Uzoq muddatli qarzning o'z kapitaliga nisbati|BNGO - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Applied DNA Sciences, Inc.|bluebird bio Inc. (BLUE) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati IPA (ImmunoPrecise Antibodies Ltd)|Uzoq muddatli majburiyatlarning kapitalga nisbati Omega Therapeutics Corp (OMGA)|Uzoq muddatli qarzning o'z kapitaliga nisbati Singular Genomics Systems OMIC|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi regulusrx.com (RGLS)|Uzoq muddatli qarzning kapitalga nisbati SYRS|Telesis Bio Inc. - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati TCON (TRACON)|Unity Biotechnology, Inc (UBX) - Uzoq muddatli qarzdorlikning kapitalga nisbati